Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Blood 2022-11, Vol.140 (Supplement 1), p.3750-3752
Hauptverfasser: Zhang, Huilai, Zhou, Keshu, Cheng, Ying, Zhang, Liling, Yang, Haiyan, Zou, Liqun, Cao, Junning, Huang, Huiqiang, Guo, Ye, Wang, Zhao, Huang, Sha, Liang, Zhiyu, Yao, Hui, Guo, Haiyi, Fang, Yiqian, Zhu, Hongjie
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3752
container_issue Supplement 1
container_start_page 3750
container_title Blood
container_volume 140
creator Zhang, Huilai
Zhou, Keshu
Cheng, Ying
Zhang, Liling
Yang, Haiyan
Zou, Liqun
Cao, Junning
Huang, Huiqiang
Guo, Ye
Wang, Zhao
Huang, Sha
Liang, Zhiyu
Yao, Hui
Guo, Haiyi
Fang, Yiqian
Zhu, Hongjie
description
doi_str_mv 10.1182/blood-2022-155979
format Article
fullrecord <record><control><sourceid>elsevier_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1182_blood_2022_155979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0006497122031767</els_id><sourcerecordid>S0006497122031767</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1859-f6f60ae38e0b9660df17a26922afe4ccc8d94556f98b5a2eb3ec53de575d951a3</originalsourceid><addsrcrecordid>eNp9kE1OwzAQRi0EEqVwAHa-QKjtxEksVlB-pUhUBTZsIsceU6PEruwUlHNwYVLCmtUsZt7MfA-hc0ouKC3Zomm91wkjjCWUc1GIAzSjnJUJIYwcohkhJE8yUdBjdBLjByE0Sxmfoe9VgNZ21skw4GdpoB-wdBrfGmOVVAP2Br9Jt2vCrrfONtg6vPRdMwK99Q5_2X6DK3Cytdp3VsN-YDX2wPVx6q6hldsIerEGE6Tq_Xjpxhqzi4ArGd4BXydLaFtcDd124zt5io6MbCOc_dU5er27fVk-JNXT_ePyqkoULblITG5yIiEtgTQiz4k2tJAsF4yNMTKlVKlFxnluRNlwyaBJQfFUAy-4FpzKdI7otFcFH2MAU2-D7UYRNSX13mr9a7XeW60nqyNzOTEwPvZpIdRRjVkVaBtA9bX29h_6B6TGg0Y</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Zhang, Huilai ; Zhou, Keshu ; Cheng, Ying ; Zhang, Liling ; Yang, Haiyan ; Zou, Liqun ; Cao, Junning ; Huang, Huiqiang ; Guo, Ye ; Wang, Zhao ; Huang, Sha ; Liang, Zhiyu ; Yao, Hui ; Guo, Haiyi ; Fang, Yiqian ; Zhu, Hongjie</creator><creatorcontrib>Zhang, Huilai ; Zhou, Keshu ; Cheng, Ying ; Zhang, Liling ; Yang, Haiyan ; Zou, Liqun ; Cao, Junning ; Huang, Huiqiang ; Guo, Ye ; Wang, Zhao ; Huang, Sha ; Liang, Zhiyu ; Yao, Hui ; Guo, Haiyi ; Fang, Yiqian ; Zhu, Hongjie</creatorcontrib><identifier>ISSN: 0006-4971</identifier><identifier>EISSN: 1528-0020</identifier><identifier>DOI: 10.1182/blood-2022-155979</identifier><language>eng</language><publisher>Elsevier Inc</publisher><ispartof>Blood, 2022-11, Vol.140 (Supplement 1), p.3750-3752</ispartof><rights>2022 The American Society of Hematology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1859-f6f60ae38e0b9660df17a26922afe4ccc8d94556f98b5a2eb3ec53de575d951a3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids></links><search><creatorcontrib>Zhang, Huilai</creatorcontrib><creatorcontrib>Zhou, Keshu</creatorcontrib><creatorcontrib>Cheng, Ying</creatorcontrib><creatorcontrib>Zhang, Liling</creatorcontrib><creatorcontrib>Yang, Haiyan</creatorcontrib><creatorcontrib>Zou, Liqun</creatorcontrib><creatorcontrib>Cao, Junning</creatorcontrib><creatorcontrib>Huang, Huiqiang</creatorcontrib><creatorcontrib>Guo, Ye</creatorcontrib><creatorcontrib>Wang, Zhao</creatorcontrib><creatorcontrib>Huang, Sha</creatorcontrib><creatorcontrib>Liang, Zhiyu</creatorcontrib><creatorcontrib>Yao, Hui</creatorcontrib><creatorcontrib>Guo, Haiyi</creatorcontrib><creatorcontrib>Fang, Yiqian</creatorcontrib><creatorcontrib>Zhu, Hongjie</creatorcontrib><title>Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma</title><title>Blood</title><issn>0006-4971</issn><issn>1528-0020</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kE1OwzAQRi0EEqVwAHa-QKjtxEksVlB-pUhUBTZsIsceU6PEruwUlHNwYVLCmtUsZt7MfA-hc0ouKC3Zomm91wkjjCWUc1GIAzSjnJUJIYwcohkhJE8yUdBjdBLjByE0Sxmfoe9VgNZ21skw4GdpoB-wdBrfGmOVVAP2Br9Jt2vCrrfONtg6vPRdMwK99Q5_2X6DK3Cytdp3VsN-YDX2wPVx6q6hldsIerEGE6Tq_Xjpxhqzi4ArGd4BXydLaFtcDd124zt5io6MbCOc_dU5er27fVk-JNXT_ePyqkoULblITG5yIiEtgTQiz4k2tJAsF4yNMTKlVKlFxnluRNlwyaBJQfFUAy-4FpzKdI7otFcFH2MAU2-D7UYRNSX13mr9a7XeW60nqyNzOTEwPvZpIdRRjVkVaBtA9bX29h_6B6TGg0Y</recordid><startdate>20221115</startdate><enddate>20221115</enddate><creator>Zhang, Huilai</creator><creator>Zhou, Keshu</creator><creator>Cheng, Ying</creator><creator>Zhang, Liling</creator><creator>Yang, Haiyan</creator><creator>Zou, Liqun</creator><creator>Cao, Junning</creator><creator>Huang, Huiqiang</creator><creator>Guo, Ye</creator><creator>Wang, Zhao</creator><creator>Huang, Sha</creator><creator>Liang, Zhiyu</creator><creator>Yao, Hui</creator><creator>Guo, Haiyi</creator><creator>Fang, Yiqian</creator><creator>Zhu, Hongjie</creator><general>Elsevier Inc</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20221115</creationdate><title>Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma</title><author>Zhang, Huilai ; Zhou, Keshu ; Cheng, Ying ; Zhang, Liling ; Yang, Haiyan ; Zou, Liqun ; Cao, Junning ; Huang, Huiqiang ; Guo, Ye ; Wang, Zhao ; Huang, Sha ; Liang, Zhiyu ; Yao, Hui ; Guo, Haiyi ; Fang, Yiqian ; Zhu, Hongjie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1859-f6f60ae38e0b9660df17a26922afe4ccc8d94556f98b5a2eb3ec53de575d951a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Huilai</creatorcontrib><creatorcontrib>Zhou, Keshu</creatorcontrib><creatorcontrib>Cheng, Ying</creatorcontrib><creatorcontrib>Zhang, Liling</creatorcontrib><creatorcontrib>Yang, Haiyan</creatorcontrib><creatorcontrib>Zou, Liqun</creatorcontrib><creatorcontrib>Cao, Junning</creatorcontrib><creatorcontrib>Huang, Huiqiang</creatorcontrib><creatorcontrib>Guo, Ye</creatorcontrib><creatorcontrib>Wang, Zhao</creatorcontrib><creatorcontrib>Huang, Sha</creatorcontrib><creatorcontrib>Liang, Zhiyu</creatorcontrib><creatorcontrib>Yao, Hui</creatorcontrib><creatorcontrib>Guo, Haiyi</creatorcontrib><creatorcontrib>Fang, Yiqian</creatorcontrib><creatorcontrib>Zhu, Hongjie</creatorcontrib><collection>CrossRef</collection><jtitle>Blood</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Huilai</au><au>Zhou, Keshu</au><au>Cheng, Ying</au><au>Zhang, Liling</au><au>Yang, Haiyan</au><au>Zou, Liqun</au><au>Cao, Junning</au><au>Huang, Huiqiang</au><au>Guo, Ye</au><au>Wang, Zhao</au><au>Huang, Sha</au><au>Liang, Zhiyu</au><au>Yao, Hui</au><au>Guo, Haiyi</au><au>Fang, Yiqian</au><au>Zhu, Hongjie</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma</atitle><jtitle>Blood</jtitle><date>2022-11-15</date><risdate>2022</risdate><volume>140</volume><issue>Supplement 1</issue><spage>3750</spage><epage>3752</epage><pages>3750-3752</pages><issn>0006-4971</issn><eissn>1528-0020</eissn><pub>Elsevier Inc</pub><doi>10.1182/blood-2022-155979</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0006-4971
ispartof Blood, 2022-11, Vol.140 (Supplement 1), p.3750-3752
issn 0006-4971
1528-0020
language eng
recordid cdi_crossref_primary_10_1182_blood_2022_155979
source Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
title Preliminary Safety and Efficacy of Zanubrutinib in Combination with Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A55%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-elsevier_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Preliminary%20Safety%20and%20Efficacy%20of%20Zanubrutinib%20in%20Combination%20with%20Lenalidomide%20in%20Patients%20with%20Relapsed/Refractory%20Diffuse%20Large%20B-Cell%20Lymphoma&rft.jtitle=Blood&rft.au=Zhang,%20Huilai&rft.date=2022-11-15&rft.volume=140&rft.issue=Supplement%201&rft.spage=3750&rft.epage=3752&rft.pages=3750-3752&rft.issn=0006-4971&rft.eissn=1528-0020&rft_id=info:doi/10.1182/blood-2022-155979&rft_dat=%3Celsevier_cross%3ES0006497122031767%3C/elsevier_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_els_id=S0006497122031767&rfr_iscdi=true